NKTCL
Clinical trials for NKTCL explained in plain language.
Never miss a new study
Get alerted when new NKTCL trials appear
Sign up with your email to follow new studies for NKTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug cocktail aims to shrink rare lymphoma before radiation
Disease control Not yet recruitingThis study tests a combination of three drugs (sintilimab, pegaspargase, and selinexor) followed by radiation in people newly diagnosed with stage I or II extranodal NK/T-cell lymphoma, a rare cancer of the immune system. The goal is to see how many patients achieve complete remi…
Matched conditions: NKTCL
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New drug duo targets hard-to-treat blood cancers
Disease control Not yet recruitingThis study tests two drugs, adebrelimab and SHR2554, together in about 40 adults whose T-cell lymphoma has come back or not responded to treatment. The goal is to find a safe dose and see if the combination can shrink tumors. Participants must have certain types of T-cell lymphom…
Matched conditions: NKTCL
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC